跳转至内容
Merck
CN
  • Comparison of long-term outcome between white and Vietnamese children treated for acute lymphoblastic leukemia according to the FRALLE 2000 protocol.

Comparison of long-term outcome between white and Vietnamese children treated for acute lymphoblastic leukemia according to the FRALLE 2000 protocol.

Journal of pediatric hematology/oncology (2013-12-11)
Phuong Thu Vu Hoang, Jérôme Ambroise, Vu Luan Dang Chi, Anne-France Dekairelle, Sophie Dupont, Nghia Huynh, Tan Binh Nguyen, Annie Robert, Jean-Luc Gala, Christiane Vermylen
摘要

To compare the relapse-free survival (RFS) in Vietnamese (n=141) and white (n=94) children living in Vietnam and Belgium, respectively, and treated in their own country for acute lymphoblastic leukemia according to the same FRALLE 2000 protocol. RFS was significantly worse in Vietnamese children (hazards ratio=4.48; 95% confidence interval [CI], 2.16-9.3; P<0.01). The 5-year RFS was 83.8% (95% CI, 76.3%-92.0%) and 47.8% (95% CI, 35.6%-64.2%) for white and Vietnamese children, respectively. In the latter group, relapses occurred in bone marrow and cerebrospinal fluid at a much earlier stage. The outcome was compared at first relapse only because of different treatments afterward, according to the country. Both series were similar for sex, age at diagnosis, initial white blood cell count, cytogenetic abnormalities, and corticosensitivity at day 8. Higher frequency of L2-acute lymphoblastic leukemia (P<0.001) but lower frequency of T-acute lymphoblastic leukemia (P=0.004) were observed in Vietnamese children. Several factors may contribute to the poor RFS in Vietnamese children, which include the time interval before the first intrathecal therapy and differences in the management of drug-related toxicity. However, additional contribution of socioeconomic factors and/or variations in pharmacogenetic polymorphisms in Vietnamese patients cannot currently be ruled out.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
甲氨蝶呤 水合物, ≥98% (HPLC), powder
Sigma-Aldrich
甲氨蝶呤 水合物, powder, BioReagent, suitable for cell culture, ≥98% (HPLC)
Sigma-Aldrich
甲氨蝶呤, meets USP testing specifications
SAFC
甲氨蝶呤
Supelco
甲氨蝶呤, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
6-巯基嘌呤 一水合物, 98%
Supelco
甲氨蝶呤,1 X 100MG 溶液, 1.0 mg/mL in methanol with 0.1N NaOH, ampule of 1 mL, certified reference material, Cerilliant®
甲氨蝶呤, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
甲氨蝶呤 水合物, ≥99.0% (sum of enantiomers, HPLC)
甲氨蝶呤, European Pharmacopoeia (EP) Reference Standard
甲氨蝶呤, European Pharmacopoeia (EP) Reference Standard